ANTX - AN2 Therapeutics, Inc.
1.15
-0.050 -4.348%
Share volume: 1,419,822
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.20
-0.05
-0.04%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-14-2024 | 08-10-2023 | 11-09-2023 | 11-13-2024 | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-25-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 16.039 M | 16.601 M | 18.180 M | 18.815 M | 18.296 M | 15.880 M | 11.771 M | 8.607 M | |
| Selling general and admin | 4.054 M | 3.063 M | 3.751 M | 3.896 M | 3.641 M | 3.731 M | 3.484 M | 3.210 M | |
| Research and development | 11.985 M | 13.538 M | 14.429 M | 14.919 M | 14.655 M | 12.149 M | 8.287 M | 5.397 M | |
| Total expenses | 16.039 M | 16.601 M | 18.180 M | 18.815 M | 18.296 M | 15.880 M | 14.014 M | 8.598 M | |
| 3.50% | 9.51% | 3.49% | -2.76% | -13.21% | -11.75% | -38.65% | |||
| Operating income | -16.039 M | -16.601 M | -18.180 M | -18.815 M | -18.296 M | -15.880 M | -14.014 M | -8.598 M | |
| Ebit | -15.323 M | -16.601 M | -16.707 M | -18.815 M | -16.617 M | -15.880 M | -12.747 M | -8.598 M | |
| Pretax income | -15.323 M | -16.601 M | -16.707 M | -16.101 M | -16.617 M | -15.880 M | -12.747 M | -6.077 M | |
| 8.34% | 0.64% | -3.63% | 3.20% | -4.44% | -19.73% | -52.33% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -15.323 M | -15.804 M | -16.707 M | -16.898 M | -16.617 M | -14.435 M | -12.747 M | -7.522 M | |
| -3.14% | -5.71% | -1.14% | 1.66% | 13.13% | 11.69% | 40.99% |
